| NCT Number | NCT04365920 |
| Lead Sponsor | Chestnut Health Systems |
| Conditions | Opioid-use Disorder |
| Enrollment | 455 participants |
| Start Date | 2021-08-29 |
| Primary Completion | 2025-04-30 (estimated) |
| Study Completion | 2025-06-30 (estimated) |
| Updated on ClinicalTrials.gov | 2025-04-06 |